Show Search Form
registered interest | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | ||||||||||||||||||||||||||||||||||
answering body |
|
|||||||||||||||||||||||||||||||||
answering dept id | 21 | |||||||||||||||||||||||||||||||||
answering dept short name | Northern Ireland | |||||||||||||||||||||||||||||||||
answering dept sort name | Northern Ireland | |||||||||||||||||||||||||||||||||
hansard heading | Cancer: Northern Ireland | |||||||||||||||||||||||||||||||||
house id | 1 | |||||||||||||||||||||||||||||||||
legislature |
|
|||||||||||||||||||||||||||||||||
question text | To ask the Secretary of State for Northern Ireland, with reference to the Department of Health in Northern Ireland (DHNI)’s press release entitled Department Announces Improved Access to New Drugs, published on 12 September 2018, what discussions she has had with the DHNI on the timeline for providing access to medicines approved for use through the Cancer Drug Fund in England; and if she will make a statement. | |||||||||||||||||||||||||||||||||
tabling member constituency | Strangford | |||||||||||||||||||||||||||||||||
tabling member printed |
|
|||||||||||||||||||||||||||||||||
uin | 188109 | |||||||||||||||||||||||||||||||||
answer |
|
|||||||||||||||||||||||||||||||||
tabling member |
|